Sony DADC BioSciences GmbH to Supply Microfluidic Cartridge for MyCartis’ EvalutionTM System – the New Generation of Rapid and Cost-Effective Diagnostic Biomarker Analysis
MyCartis, the provider of fully integrated and broadly applicable molecular diagnostics and immunodiagnostics solutions, and Sony DADC BioSciences today announced the cooperation in the production of a microfluidic assay cartridge for MyCartis’ EvalutionTM digital multiplex analysis platform to support a range of applications in the clinical research and pharmaceutical markets and designed to analyze a broad range of protein and nucleic acid-based biomarkers.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160229005056/en/
Microfluidic cartridge for MyCartis’ Evalution(TM) System (Sony DADC BioSciences GmbH/mphoto)
Sony DADC BioSciences, a leading supplier of smart polymer parts for the biomedical industry, is using their ISO 13485-certified facility in Salzburg, Austria for manufacturing. The customized foil bonded cartridge is manufactured as a monolithic molded microtiter size plate that has optical transparency and combines macrostructures, high precision microstructures and filter structures for achieving the ultra-sensitivity of the EvalutionTM System.
“We are very pleased to be working with Sony DADC BioSciences as our development and manufacturing partner for the EvalutionTM cartridge. The collaboration between the two companies brings together a broad range of knowledge and experience, which are important for the success of innovative new technologies such as the EvalutionTM System,” said Joris Schuurmans, CEO of MyCartis.
The highly integrated assay cartridge contains reaction and detection chambers to ensure short time to result and minimal processing steps. Next to the ability to run 1 to 16 samples at the same time the EvalutionTM System further delivers superior data quality and rapid results.
“We are fascinated about MyCartis’ flexible EvalutionTM platform and enjoy our mutual team spirit. From a manufacturing perspective, the project enhances our capabilities in both injection molding and bonding of microfluidic consumables in micro titer plate format – the de facto industry standard,” said Werner Balika, Engineering Manager at Sony DADC BioSciences GmbH.
MyCartis' innovative research and diagnostic system, called EvalutionTM, features the measurement and detection of molecular components of different nature (proteins, nucleic acids…), indicative of a specific pathological state in a multiplex format. The new semi-automated system is highly user-friendly thanks to its integrated workflow and provides rapid and robust results thanks to improved kinetics in the microfluidic channels. In addition, MyCartis develops ready-to-use multiplex assays with major clinical and compelling health economic values, through its own development efforts as well as through strategic partnerships. Oncology, neurology, cardiology and immunology are MyCartis' primary focus.
For more information please visit http://www.mycartis.net/
About Sony DADC BioSciences GmbH
Building on Sony DADC’s experience in high-precision optical disc manufacturing, Sony DADC BioSciences partners with Life Sciences and Diagnostics companies enabling the industrial manufacturing of smart polymer parts.
For more information please visit http://biosciences.sonydadc.com
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
SmartStream and Credit Suisse Expand their Agreement from the Processing of Invoices and Reconciliations to Now Include Listed Derivatives Brokerage Fees18.10.2017 12:00 | Pressemelding
SmartStream Technologies, the financial Transaction Lifecycle Management (TLM®) solutions provider, today announced that its original agreement with Credit Suisse was recently expanded to include the processing of Listed Derivatives Brokerage fees which began in February of this year. This expansion in SmartStream’s partnership with Credit Suisse complements its existing managed service solution for the processing of invoices and reconciliations within Credit Suisse’s OTC Fixed Income Derivatives, US Listed Equity Options and Cash Equities businesses across brokerage, clearing and exchange fees operations, which began in June of 2016. The managed service enables the bank to advance the operational efficiencies created through the use of the utility-based solutions offered by SmartStream, utilizing their proprietary execution fees and expense management software. By centralizing the ent
Biogen Confirms Commitment to Tackle Multiple Sclerosis Through Comprehensive Approach18.10.2017 11:30 | Pressemelding
Biogen (NASDAQ: BIIB) confirms its comprehensive approach to tackle multiple sclerosis (MS) at the seventh Joint Meeting of the European Committee for Treatment and Research in MS and Americas Committee for Treatment and Research in MS (ECTRIMS-ACTRIMS; 25 – 28 October). “With more than 25 years of scientific leadership in MS, Biogen’s commitment is unwavering,” said Michael Ehlers, executive vice president, Research & Development at Biogen. “Our expertise puts Biogen in a unique position with a comprehensive approach including active research and clinical development on how to repair the damage to the central nervous system from relapsing forms of MS, a portfolio of new drug candidates that we are advancing to the clinic, our collaboration to identify a digital biomarker, our focus to advance understanding of the disease through global data collection with MS PATHS, active pursuit
Scientist.com Collaborates With UKCRC Tissue Directory and Coordination Centre to Ensure Quality of Human Biosample Acquisition Globally18.10.2017 11:01 | Pressemelding
Scientist.com, the world’s leading marketplace for outsourced scientific services, today announced that it is entering into a collaboration with the UKCRC Tissue Directory and Coordination Centre (UKCRC TDCC) to support the work of biobanks throughout the United Kingdom. The partnership will enable drug R&D to move forward more quickly by making large collections of prescreened human biological samples available for scientific research. Through the new COMPLI™ feature, Scientist.com provides a simple, efficient and effective way of increasing the visibility and accessibility of biobanks’ human biological samples collections, which support new medical research. COMPLI™ introduces a common, comprehensive process and supply agreement supporting access to human biosamples. The goal is to enable biobanks to more easily connect with researchers in the pharmaceutical and biotech indust
Assurant to Acquire the Warranty Group in Transaction Valued at $2.5 Billion18.10.2017 10:30 | Pressemelding
Assurant, Inc. (NYSE:AIZ), a premier global provider of risk management solutions, and The Warranty Group, a leading global provider of protection plans and related programs, and a portfolio company of TPG Capital, today announced that they have entered into a definitive agreement to combine operations, with Assurant shareholders retaining majority ownership of the combined company. The transaction is valued at approximately $2.5 billion and is expected to close in the first half of 2018, subject to shareholder and regulatory approvals, and other customary closing conditions. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171018005269/en/ The transaction will significantly advance Assurant’s strategy in the global lifestyle market with an attractive product and client portfolio, diversified growth profile and a deeper glob
Boost the Connectivity and Memory on Your Phone with FuZion18.10.2017 09:47 | Pressemelding
IDEMIA (formerly known as OT-Morpho), the global leader in trusted identities for an increasingly digital world, today announces the solution for a problem everyone encounters: the choice between connectivity and memory for one’s smartphone. With FuZion, a fantastic device combining the technologies of a SIM card with a microSD card, users will never have to make this choice again. Nowadays, most people need to have two SIM cards, one for personal use and the other for a professional one. At the same time, people require their smartphone to have a lot of memory. That is why today, more and more smartphones have a dual SIM tray, with a hybrid slot for two SIM cards or for one SIM card and a microSD card. With FuZion, no compromises: users can simultaneously have two SIM cards and a microSD card in their phone. FuZion is available for more than 50 smartphone models from
Capgemini Gives Technology a Human Touch, with a New Brand Identity Designed by BrandPie.18.10.2017 08:30 | Pressemelding
Capgemini, one of the world’s leading global technology and consulting firms, yesterday launched its new brand identity, designed by strategic brand consultancy BrandPie. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171018005101/en/ Capgemini's new brand identity, designed by BrandPie BrandPie worked in close collaboration with Capgemini’s leadership team over 15 months to create a dynamic digital-first brand identity and wordmark, inspired by the handwriting of Serge Kampf, Capgemini’s founder. Meanwhile, its iconic spade emblem has been redrawn to reflect the world the business is now in. Coinciding with the Group’s 50th anniversary, this is the first overhaul of Capgemini’s brand identity since 2004, and has been crafted to ensure that it remains ahead of its peers in its
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom